Louis J. Paglia, Director at Bioverativ Inc. (BIVV), bought 2,000 shares at $59.70 ($119K) on 2017-08-07, disclosed to the SEC on 2017-08-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NRF | BUY | 2008-12-22 | $20K | — | Filing → |
| UIL | SELL | 2006-07-26 | $1.2M | — | Filing → |
| NRF | BUY | 2006-05-24 | $109K | — | Filing → |